Histologic analysis of tumor sections showed a markedly decreased cellularity in Salinomycin+TRAIL-treated mice, compared to all other experimental groups (NT, Salinomycin or TRAIL) (Fig. 9C). The gene discussed is TNFSF10; the disease is neoplasm.